UniProt ID | RRP8_HUMAN | |
---|---|---|
UniProt AC | O43159 | |
Protein Name | Ribosomal RNA-processing protein 8 | |
Gene Name | RRP8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 456 | |
Subcellular Localization | Nucleus, nucleolus . Localizes at rDNA locus. | |
Protein Description | Essential component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. In the complex, RRP8 binds to H3K9me2 and probably acts as a methyltransferase. Its substrates are however unknown.. | |
Protein Sequence | MFEEPEWAEAAPVAAGLGPVISRPPPAASSQNKGSKRRQLLATLRALEAASLSQHPPSLCISDSEEEEEERKKKCPKKASFASASAEVGKKGKKKCQKQGPPCSDSEEEVERKKKCHKQALVGSDSAEDEKRKRKCQKHAPINSAQHLDNVDQTGPKAWKGSTTNDPPKQSPGSTSPKPPHTLSRKQWRNRQKNKRRCKNKFQPPQVPDQAPAEAPTEKTEVSPVPRTDSHEARAGALRARMAQRLDGARFRYLNEQLYSGPSSAAQRLFQEDPEAFLLYHRGFQSQVKKWPLQPVDRIARDLRQRPASLVVADFGCGDCRLASSIRNPVHCFDLASLDPRVTVCDMAQVPLEDESVDVAVFCLSLMGTNIRDFLEEANRVLKPGGLLKVAEVSSRFEDVRTFLRAVTKLGFKIVSKDLTNSHFFLFDFQKTGPPLVGPKAQLSGLQLQPCLYKRR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
43 | Phosphorylation | KRRQLLATLRALEAA HHHHHHHHHHHHHHH | 19.42 | 20068231 | |
51 | Phosphorylation | LRALEAASLSQHPPS HHHHHHHHHHCCCCC | 35.28 | 29255136 | |
53 | Phosphorylation | ALEAASLSQHPPSLC HHHHHHHHCCCCCCC | 24.77 | 25463755 | |
58 | Phosphorylation | SLSQHPPSLCISDSE HHHCCCCCCCCCCCH | 40.08 | 30266825 | |
62 | Phosphorylation | HPPSLCISDSEEEEE CCCCCCCCCCHHHHH | 33.80 | 29255136 | |
64 | Phosphorylation | PSLCISDSEEEEEER CCCCCCCCHHHHHHH | 39.87 | 29255136 | |
78 | Acetylation | RKKKCPKKASFASAS HHHHCCHHHHHHHHH | 34.11 | 26051181 | |
80 | Phosphorylation | KKCPKKASFASASAE HHCCHHHHHHHHHHH | 30.17 | 25159151 | |
83 | Phosphorylation | PKKASFASASAEVGK CHHHHHHHHHHHHHH | 22.27 | 20873877 | |
85 | Phosphorylation | KASFASASAEVGKKG HHHHHHHHHHHHHHC | 23.59 | 28188228 | |
90 | Acetylation | SASAEVGKKGKKKCQ HHHHHHHHHCHHHHH | 64.63 | 26051181 | |
90 | 2-Hydroxyisobutyrylation | SASAEVGKKGKKKCQ HHHHHHHHHCHHHHH | 64.63 | - | |
104 | Phosphorylation | QKQGPPCSDSEEEVE HHCCCCCCCCHHHHH | 50.36 | 29255136 | |
106 | Phosphorylation | QGPPCSDSEEEVERK CCCCCCCCHHHHHHH | 30.52 | 29255136 | |
124 | Phosphorylation | HKQALVGSDSAEDEK HHHHHCCCCCHHHHH | 22.40 | 29255136 | |
126 | Phosphorylation | QALVGSDSAEDEKRK HHHCCCCCHHHHHHH | 34.94 | 29255136 | |
131 | Acetylation | SDSAEDEKRKRKCQK CCCHHHHHHHHHHHH | 75.45 | 26051181 | |
138 | Acetylation | KRKRKCQKHAPINSA HHHHHHHHHCCCCHH | 51.72 | 26051181 | |
144 | Phosphorylation | QKHAPINSAQHLDNV HHHCCCCHHHCCCCC | 29.99 | 28555341 | |
154 | Phosphorylation | HLDNVDQTGPKAWKG CCCCCCCCCCCCCCC | 51.49 | 28555341 | |
157 | Sumoylation | NVDQTGPKAWKGSTT CCCCCCCCCCCCCCC | 69.12 | - | |
157 | Ubiquitination | NVDQTGPKAWKGSTT CCCCCCCCCCCCCCC | 69.12 | 29967540 | |
157 | Sumoylation | NVDQTGPKAWKGSTT CCCCCCCCCCCCCCC | 69.12 | - | |
162 | Phosphorylation | GPKAWKGSTTNDPPK CCCCCCCCCCCCCCC | 28.47 | 23927012 | |
163 | Phosphorylation | PKAWKGSTTNDPPKQ CCCCCCCCCCCCCCC | 37.98 | 23927012 | |
164 | Phosphorylation | KAWKGSTTNDPPKQS CCCCCCCCCCCCCCC | 39.04 | 23663014 | |
171 | Phosphorylation | TNDPPKQSPGSTSPK CCCCCCCCCCCCCCC | 37.04 | 23927012 | |
174 | Phosphorylation | PPKQSPGSTSPKPPH CCCCCCCCCCCCCCC | 29.15 | 23401153 | |
175 | Phosphorylation | PKQSPGSTSPKPPHT CCCCCCCCCCCCCCC | 55.77 | 30266825 | |
176 | Phosphorylation | KQSPGSTSPKPPHTL CCCCCCCCCCCCCCC | 32.40 | 30266825 | |
182 | Phosphorylation | TSPKPPHTLSRKQWR CCCCCCCCCCHHHHH | 32.00 | 22167270 | |
184 | Phosphorylation | PKPPHTLSRKQWRNR CCCCCCCCHHHHHHH | 38.29 | 22167270 | |
201 | Sumoylation | NKRRCKNKFQPPQVP HHHHHCCCCCCCCCC | 30.76 | - | |
201 | Sumoylation | NKRRCKNKFQPPQVP HHHHHCCCCCCCCCC | 30.76 | - | |
201 | Acetylation | NKRRCKNKFQPPQVP HHHHHCCCCCCCCCC | 30.76 | 26051181 | |
217 | Phosphorylation | QAPAEAPTEKTEVSP CCCCCCCCCCCCCCC | 58.10 | 24732914 | |
220 | Phosphorylation | AEAPTEKTEVSPVPR CCCCCCCCCCCCCCC | 35.07 | 30266825 | |
223 | Phosphorylation | PTEKTEVSPVPRTDS CCCCCCCCCCCCCCC | 17.59 | 29255136 | |
228 | Phosphorylation | EVSPVPRTDSHEARA CCCCCCCCCCHHHHH | 35.47 | 24732914 | |
230 | Phosphorylation | SPVPRTDSHEARAGA CCCCCCCCHHHHHHH | 23.71 | 28111955 | |
259 | Phosphorylation | RYLNEQLYSGPSSAA HHHHHHHHCCCCHHH | 15.98 | 27642862 | |
286 | Phosphorylation | LYHRGFQSQVKKWPL HHCCCCHHHHHCCCC | 34.38 | 21712546 | |
309 | Phosphorylation | DLRQRPASLVVADFG HHHHCCCCEEEEECC | 25.12 | 27080861 | |
401 | Methylation | SSRFEDVRTFLRAVT HHHHHHHHHHHHHHH | 31.89 | 115492947 | |
409 | Malonylation | TFLRAVTKLGFKIVS HHHHHHHHHCCEEEE | 39.76 | 26320211 | |
409 | Acetylation | TFLRAVTKLGFKIVS HHHHHHHHHCCEEEE | 39.76 | 25953088 | |
413 | Acetylation | AVTKLGFKIVSKDLT HHHHHCCEEEECCCC | 40.16 | 26051181 | |
417 | Acetylation | LGFKIVSKDLTNSHF HCCEEEECCCCCCCE | 45.95 | 26051181 | |
431 | Ubiquitination | FFLFDFQKTGPPLVG EEEEEECCCCCCCCC | 56.28 | - | |
440 | Sumoylation | GPPLVGPKAQLSGLQ CCCCCCCCHHHCCCC | 42.72 | - | |
440 | Sumoylation | GPPLVGPKAQLSGLQ CCCCCCCCHHHCCCC | 42.72 | - | |
440 | Ubiquitination | GPPLVGPKAQLSGLQ CCCCCCCCHHHCCCC | 42.72 | 29967540 | |
454 | Sumoylation | QLQPCLYKRR----- CCCCCCCCCC----- | 28.84 | - | |
454 | Sumoylation | QLQPCLYKRR----- CCCCCCCCCC----- | 28.84 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RRP8_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RRP8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RRP8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62 AND SER-64, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-64; SER-104;SER-106; SER-124 AND SER-126, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-64; SER-171;THR-175 AND SER-223, AND MASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62 AND SER-64, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124 AND SER-126, ANDMASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-171 AND SER-176, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-223, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-64; SER-104 ANDSER-106, AND MASS SPECTROMETRY. |